Your session is about to expire
← Back to Search
Orthotics
3D-Printed Orthotics for Plantar Fasciitis
N/A
Waitlist Available
Research Sponsored by Prisma Health-Midlands
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 8 weeks
Awards & highlights
No Placebo-Only Group
Summary
This trial tests a new method using 3D printing to make custom foot inserts for people with plantar fasciitis. It aims to see if these inserts work better than traditional ones and if patients are satisfied with them. 3D printed foot orthoses have been shown to be effective in treating various foot conditions, including plantar fasciitis, by improving foot biomechanics and comfort.
Who is the study for?
This trial is for adults over 18 with plantar fasciitis who can communicate electronically. It's not suitable for non-English speakers, Medicare patients, pregnant women, those needing lower leg bracing, or individuals with a history of orthotic use or certain foot conditions.
What is being tested?
The study compares the effectiveness and patient satisfaction between HP Arize 3D-printed orthotics and traditional custom-made ones in treating plantar fasciitis. Participants will receive one type to see which performs better.
What are the potential side effects?
While specific side effects are not listed for wearing orthotics, some may experience discomfort or pain during initial use as their feet adjust to the new support provided by the inserts.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 8 weeks
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~8 weeks
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
Patient-reported compliance and satisfaction with orthotics.
Secondary study objectives
Patient-reported secondary site pain following implementation of orthotics.
Awards & Highlights
No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.
Trial Design
2Treatment groups
Experimental Treatment
Active Control
Group I: HP Arize 3D-Printed OrthoticsExperimental Treatment1 Intervention
Patients will receive the HP Arize 3D-printed orthotics for treatment of plantar fasciitis.
Group II: Traditional OrthoticsActive Control1 Intervention
Patients will receive traditionally fabricated orthotics for treatment of plantar fasciitis.
Research Highlights
Information in this section is not a recommendation. We encourage patients to speak with their healthcare team when evaluating any treatment decision.Mechanism Of Action
Side Effect Profile
Prior Approvals
Other Research
Custom foot orthoses, especially those created using 3D printing technology, provide tailored support to the arch of the foot, redistribute pressure, and improve foot alignment. This reduces strain on the plantar fascia, alleviates pain, and promotes healing.
The precision of 3D printing allows for a more accurate fit, enhancing the effectiveness of the orthoses. For Plantar Fasciitis patients, this personalized approach is crucial for effective management and relief.
Find a Location
Who is running the clinical trial?
Hewlett-Packard (HP)UNKNOWN
Prisma Health-MidlandsLead Sponsor
23 Previous Clinical Trials
2,765 Total Patients Enrolled
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- You have used or been prescribed orthotic inserts in the past.You have been diagnosed with nerve damage, a recent broken bone, or a bone fracture caused by overuse or repetitive stress.You need to wear extra support on your lower leg.You have been diagnosed with plantar fasciitis.
Research Study Groups:
This trial has the following groups:- Group 1: Traditional Orthotics
- Group 2: HP Arize 3D-Printed Orthotics
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.